Cannabis Science Inc (OTCMKTS:CBIS) a celebrated firm in the U.S. focusing on the formulation of cannabis-based drugs, is all established to cash in on new market prospects in Nevada and California after the election. It is now targeting around 1,000 acres in the two regions for drug and property advancement plans. The post-election plan comprises new products, dispensaries, and also strategic programs.

The experts view

Raymond C. Dabney, who is the CEO of Cannabis Science, stated that after concluding the land deal they confirmed for over 300 acres. However, they are looking at a broader perspective after the recent developments. This package complement other significant deals in Nevada and California. All these deals put firm in a favorable place for robust growth in approaching period.

Together with finishing in-house lab, new site and advanced drug plans, they have some exhilarating advancements impending in the future. The management feel set to fulfill the increasing demand than ever before. After the completion of historic election, the company finds this as the best time for implementing its plans. Also, following the notable support for Proposition 64 and numerous other pro-cannabis initiatives across the nation, Cannabis Science is in a much better position to excel in the budding industry.

Both Nevada and California participated in the electoral process to sanction pot for recreational use. This development can bring immense benefits for the firm. It allows for increased pathways for customers to get the firm’s products. The fact that California comes in the group of largest economies across the globe when seen in terms of GDP, the latest reforms opens a large market for Cannabis Science to explore.

Lately, articles have been issued broadcasting that sales of cannabis in Colorado can excel alcohol sales in next couple of years. In California’s broader market, the consumer backing in the marijuana market has remarkable scope to support company’s bottom line.

To benefit from this recent developments, Cannabis Science has been working on its drug advancement land agreements. It will help the firm to introduce increased products and meet customers’ demand.